Wooldridge James

CIK 00017106412 companiesAUSTIN, TX

Transactions

Companies

Filings

CIK

0001710641

Recent Transactions

13 trades

Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−27,300→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−101,180→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−54,600→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−150,818→ 0 total
Disposition to Issuer
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-31−95,916→ 0 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-01-27+101,180→ 101,180 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-08-04+27,300→ 27,300 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-03-04+54,600→ 54,600 total
Award
Checkmate Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-08-06+150,818→ 150,818 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2019-02-28+50,200→ 50,200 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2018-02-20+45,000→ 45,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2017-08-22+165,000→ 165,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Employee Stock Option (right to buy)
2017-08-22+10,000→ 10,000 total

C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250

AUSTIN, TX, 78746